1017 / 1161
Recommendations for IMRT use
1) If the
reduction of xerostomia
and improved quality of
life are the main outcomes of interest, then
IMRT
is the
recommended
treatment
2) If
blindness
is to be minimized or avoided,
IMRT
is
indicated
in the definitive or adjuvant radiotherapy setting for nasal and
paranasal sinus cancers
3) If
osteoradionecrosis
is to be minimized or avoided,
IMRT
is
indicated
in the definitive or adjuvant radio- therapy of
tumours in the oral cavity, oropharynx, paranasal sinuses and
nasopharynx
O’Sullivan, B., Rumble, R. B., & Warde, P. (2012). Intensity-modulated Radiotherapy in
the Treatment of Head and Neck Cancer. Clinical Oncology, 24(7), 474–487